A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.

Collins, RC; Espinoza, LR; Plank, CR; Ebers, GC; Rosenberg, RA; Zabriskie, JB

Abstract:

A double-blind trial of the effect of transfer factor on multiple sclerosis patients was carried out. In a series of fifty-six multiple sclerosis patients treated with monthly injections of either transfer factor or placebo for 1 year, no beneficial effect of transfer factor was noted. In addition, none of the immunological and serological parameters studied (measles migration inhibition, measles HI titre or CSF immunoglobulin) changed as a result of transfer factor therapy. Histocompatibilit...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Collins, R. C., Espinoza, L. R., Plank, C. R., Ebers, G. C., Rosenberg, R. A., & Zabriskie, J. B. (1978). A double-blind trial of transfer factor vs placebo in multiple sclerosis patients. Clinical and Experimental Immunology, 33(1), 1–11.

MLA Style

Collins, R. C., et al. “A Double-Blind Trial of Transfer Factor vs Placebo in Multiple Sclerosis Patients.” Clinical and Experimental Immunology, vol. 33, no. 1, 1978, pp. 1–11.

Chicago Style

Collins, RC, LR Espinoza, CR Plank, GC Ebers, RA Rosenberg, and JB Zabriskie. 1978. “A Double-Blind Trial of Transfer Factor vs Placebo in Multiple Sclerosis Patients.” Clinical and Experimental Immunology 33 (1): 1–11.
Tweet
Print